Suppression of choroidal neovascularization by intravitreal injection of liposomal SU5416.
about
Liposomes and nanotechnology in drug development: focus on ocular targetsIntravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat modelSuppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin.Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye.Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.Drug delivery techniques for treating age-related macular degeneration.Intravitreal drug delivery in retinal disease: are we out of our depth?Nanocarriers of nanotechnology in retinal diseases.Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.Current advances in the treatment of neovascular age-related macular degeneration.Drug delivery to the eye: what benefits do nanocarriers offer?Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab.Safe dose of intravitreal imatinib and its effect on laser-induced choroidal neovascularization: a rat-model experiment.Effective Delivery of Exogenous Compounds to the Optic Nerve by Intravitreal Injection of Liposome
P2860
Q27687657-1B09C9F9-0462-48B6-BEE5-B08028D495C9Q34652557-220CA198-85C7-41F9-91B1-DA6D39C6EC09Q34735778-3A7C9022-93C2-4ED7-86F3-C743C319F689Q35262576-E06DC0B3-28C7-43A1-9331-0B742DBE73C5Q38100561-04C27E7D-3803-4282-97DD-CB912EC256A8Q38161953-AE277244-2F5C-445B-B72B-E19BE73A07C7Q38220453-5231F854-20A1-493B-8D99-7587084F584DQ38282885-395840C7-8A28-40C0-BB89-F942147241C7Q38837906-61DC9E9E-375B-4995-8972-46671A17680FQ38902191-325D59DC-CDA2-472D-92D0-C1CD647C948DQ39130097-1CE94BAE-1180-411A-8D64-18593834CF86Q47156996-6142DE0E-1FF0-4DA8-A2A2-4085FA82B2CAQ51099974-504A8825-9BAB-4E82-A604-68E2678BEF13Q57488293-2F31269E-BB25-4059-83F8-4846E74014C3
P2860
Suppression of choroidal neovascularization by intravitreal injection of liposomal SU5416.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Suppression of choroidal neova ...... injection of liposomal SU5416.
@ast
Suppression of choroidal neova ...... injection of liposomal SU5416.
@en
type
label
Suppression of choroidal neova ...... injection of liposomal SU5416.
@ast
Suppression of choroidal neova ...... injection of liposomal SU5416.
@en
prefLabel
Suppression of choroidal neova ...... injection of liposomal SU5416.
@ast
Suppression of choroidal neova ...... injection of liposomal SU5416.
@en
P2093
P1433
P1476
Suppression of choroidal neova ...... injection of liposomal SU5416.
@en
P2093
Miki Honda
Minoru Tanaka
Takuya Umemoto
Tomohiro Asai
Yoshihiko Araki
P304
P356
10.1001/ARCHOPHTHALMOL.2011.12
P407
P577
2011-03-01T00:00:00Z